GSC
ELV icon

G&S Capital’s Elevance Health ELV Stock Holding History

G&S Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,740
Closed -$893K – 113
2022
Q4 		$893K Buy
1,740
+971
+126% +$493K 0.4% 66
2022
Q3 		$349K Sell
769
-4,154
-84% -$1.99M 0.19% 82
2022
Q2 		$2.38M Buy
+4,923
New +$2.44M 1.4% 24

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

G&S Capital's ELV Position: Q1 2023 in Review

G&S Capital sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 1,740 shares — an estimated $893K sold.

G&S Capital first reported a position in ELV in Q2 2022 and held it in 3 quarters. The position peaked at $2.38M in Q2 2022. 1,517 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • G&S Capital reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • G&S Capital sold 1,740 Elevance Health shares in Q1 2023, an estimated $893K.
  • G&S Capital first reported a position in Elevance Health in Q2 2022 and held it in 3 quarters.
  • G&S Capital's Elevance Health position peaked at $2.38M in Q2 2022.
  • 1,517 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on G&S Capital's 13F filing for Q1 2023, filed 21 Apr 2023.